002030 Daan Gene Co.,Ltd.
- 6.42
- -0.03-0.47%
Daan Gene Co.,Ltd. News
Daan Gene: Report for the third quarter of 2024
daan gene co.,ltd. (002030.SZ) released its performance for the first three quarters, with a net loss of 0.503 billion yuan.
daan gene co.,ltd. (002030.SZ) released the third quarter report of 2024, the company's revenue in the first three quarters was 5...
Daan Gene's Unit Gets Registration Certificate for Alpha-Fetoprotein Kit
daan gene co.,ltd. (002030.SZ) subsidiary has obtained a medical instruments registration certificate.
daan gene co.,ltd. (002030.SZ) announced that its wholly-owned subsidiary, Guangzhou Datai Biotechnology Engineering Technology Co., Ltd...
daan gene co.,ltd. (002030.SZ): The wholly-owned subsidiary received a cash dividend of 0.4634 million yuan.
Gelonghui, September 26th, daan gene co.,ltd. (002030.SZ) announced that its wholly-owned subsidiary, Guangzhou Daan Gene Technology Co., Ltd. (hereinafter referred to as "Daan Technology"), recently received cash dividends from its shareholding company, Zhuhai Yasha Biotechnology Co., Ltd. (hereinafter referred to as "Yasha Company"), as follows: According to the resolution of Yasha Company's 2024 third interim shareholders' meeting, the profit distribution plan is as follows: based on the existing total share capital of 41,927,609 shares, each shareholder will receive 1.2 RMB cash for every 10 shares. Daan Technology, a wholly-owned subsidiary of the company, holds a stake in Yasha Company
Daan Gene Co., Ltd. (002030.SZ): Cooperating with an independent medical laboratory to carry out some tumor gene testing projects.
Daan Gene Co.,Ltd. (002030.SZ) stated during investor relations activities that the overall sales volume of the company's products is showing an increasing trend. Tumor detection products such as EB, HPV, etc. have certain sales; in addition, the company collaborates with independent medical laboratories to carry out some tumor gene detection projects.
Express News | daan gene co.,ltd.: Currently, most of the prices of molecular diagnostic products have significantly decreased compared to before.
Daan Gene Gets Approval for Whopping Cough Detection Kit
Express News | Daan Gene Co., Ltd.: Obtained the registration certificate for pertussis nucleic acid detection kit.
Express News | daan gene co.,ltd.: The monkeypox reagent kit has been sold to the domestic market.
Daan Gene: 2024 Semi-Annual Report
Daan Gene: 2024 Semi-Annual Report Summary
daan gene co.,ltd. (002030.SZ): a net loss of 0.399 billion yuan in the first half of the year.
GeLonghui, August 30 - DaAn Gene Co.,Ltd. (002030.SZ) released its 2024 interim report, during the reporting period, the company achieved revenue of 0.4 billion yuan, a year-on-year decrease of 25.33%; the net income attributable to shareholders of the listed company was -0.399 billion yuan, a year-on-year change from profit to loss; the net income attributable to shareholders of the listed company, excluding non-recurring gains and losses, was -0.179 billion yuan; basic earnings per share was -0.28 yuan.
Daan Gene Co., Ltd. (002030.SZ): Its wholly-owned subsidiary received cash dividend of 4.1957 million Hong Kong dollars.
Daan Gene Co.,Ltd. (002030.SZ) announced on August 28th that according to the Shareholders' Annual General Meeting of Yun Kang Group held on June 28th, 2024, the proposal of "declaring a cash dividend of HKD 0.02 per share for the year ending December 31, 2023, to be allocated from the company's share premium account" was approved. Daan International, a wholly-owned subsidiary of the company, holds 209,783,000 shares of Yun Kang Group. The amount of cash dividend for this distribution is HKD 4,195,660.00. Recently, Daan International, a wholly-owned subsidiary of the company, has received the above-mentioned cash dividend of HKD 4,195,660.00.
Express News | daan gene co.,ltd.: obtained two medical instruments registration certificates
Express News | A subsidiary of Sinopharm Group sues Daan Gene Co., Ltd.
Daan Gene Gets Medical Device Registration Certificate for Monkeypox Detection Kit
A shares smallpox concept rises against the trend, Hainan Poly Pharm increases by more than 8%.
On August 20th, Hainan Poly Pharm rose more than 8%, and Hicin Pharmaceutical, which had almost hit the 20% limit down in the morning, continued to rebound and rose more than 5%. Daan Gene, Lanwei Medicine, Guangdong Hybribio Biotech, Yunningwei, Xiduo Pharmaceuticals and others followed the trend. On the news front, the global monkeypox epidemic has attracted attention recently. The World Health Organization has issued its second highest-level warning on the monkeypox epidemic since July 2022, announcing that the monkeypox epidemic constitutes an "unexpected public health emergency of international concern."
Express News | Daan Gene Co., Ltd. obtained the medical instrument registration certificate for the monkeypox virus nucleic acid detection kit.
Daan Gene Co., Ltd. (002030.SZ): Recently, the company's monkeypox virus nucleic acid detection kit has not been sold to the African market temporarily.
Daan Gene Co.,Ltd. (002030.SZ) stated on the investor interaction platform on August 16th that the company's Monkeypox virus nucleic acid detection kit (fluorescent PCR method) has not been sold to the African market recently.
Analysis
Price Target
No Data
No Data